4//SEC Filing
Satlin Andrew 4
Accession 0001209191-20-011303
CIK 0001567514other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 7:27 PM ET
Size
8.0 KB
Accession
0001209191-20-011303
Insider Transaction Report
Form 4
Satlin Andrew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-18+26,754→ 26,754 totalExercise: $23.94Exp: 2030-02-17→ Common Stock (26,754 underlying) - Award
Restricted Stock Units
2020-02-18+33,417→ 33,417 total→ Common Stock (33,417 underlying)
Footnotes (3)
- [F1]On February 18, 2020, the reporting person was granted options to purchase 26,754 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On February 18, 2020, the reporting person was granted 33,417 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001722858
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 7:27 PM ET
- Size
- 8.0 KB